Patient-derived mouse models that let drugs be tried against a patient's own tumor tissue first.
Consented intake · your records travel with you · nothing moves without your sign-off
Certis Oncology builds patient-derived mouse models (PDX) from a patient's tumor tissue and tests drugs on them. The idea is simple: try candidate treatments on a living model of the specific cancer before trying them on the patient. This can help patients and their doctors compare options using evidence drawn from their own tumor.
Prefer the source? Certis Oncology (mouse models)'s own site has more.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Certis Oncology (mouse models) handles billing.
We don't have confirmed insurance details for Certis Oncology (mouse models) yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in Certis's details here. Educational only; your oncologist directs treatment.
Powered by Navis on opencancer.ai
Other providers in similar categories.
Gather distinctive biomarkers that can guide treatment and monitor disease progression
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Matches your tumor's biomarkers to the therapies most likely to work for you — mapping your molecular profile to targeted and approved options.
This page is general information. Upload your records for analysis specific to YOUR diagnosis.